豪洛捷 HOLX 深 沪
等待开盘 08-14 09:30:00 美东时间
68.92
+0.970
+1.43%
华盛通- 最 高69.13
- 今 开67.85
- 成交量 130.05万股
- 最 低 67.82
- 昨 收 67.95
- 总市值 153.00亿
- 52周最高 84.39
- 市盈率 静 20.74
- 换手率 0.00%
- 52周最低 51.90
- 委 比 38.53%
- 总股本 2.22亿
- 历史最高 87.88
- 量 比 0.92
- 振 幅 1.93%
- 历史最低 13.90
- 每 手 1
- 风险率 4.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多22.5亿美元医疗黑科技炸场：美敦力、强生、GE医疗等巨头疯狂入局
（来源：医趋势） 8月7日，美国医疗器械企业HistoSonics宣布，一个由私募和公募投资者组成的联盟已完成对其多数股权的收购，此次收购由公司管理层主导。...
08-11 12:05
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
RBC Capital Upgrades Hologic to Outperform, Raises Price Target to $87
RBC Capital analyst Conor McNamara upgrades Hologic (NASDAQ:HOLX) from Sector Perform to Outperform and raises the price target from $72 to $87.
08-07 00:58
Hologic (HOLX) Gets a Hold from Evercore ISI
Evercore ISI analyst Vijay Kumar maintained a Hold rating on Hologic today and ...
08-01 01:55
Hologic shares are trading higher after the company reported better-than-expected Q3 financial results, raised its FY25 adjusted EPS guidance, and issued Q4 adjusted EPS guidance above estimates.
Hologic shares are trading higher after the company reported better-than-expect...
07-31 04:38
Hologic Sees Q4 Adj EPS $1.09-$1.12 vs $1.07 Est; Sees Sales $1.030B-$1.040B vs $1.034B Est
Hologic's financial guidance for the fourth quarter and full year 2025 is shown in the table below. The guidance is based on a full year non-GAAP tax rate of approximately 19.25%, and diluted shares outstanding of
07-31 04:04
West Welcomes Robert McMahon as Incoming Chief Financial Officer
EXTON, Pa., July 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the appo...
07-21 18:00
Hologic Refinances Loan to Enhance Financial Flexibility
An announcement from Hologic ( ($HOLX) ) is now available. On July 15, 2025, Ho...
07-18 20:48
Mizuho Maintains Outperform on Hologic, Raises Price Target to $70
Mizuho analyst Anthony Petrone maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $65 to $70.
07-16 20:27
Notable analyst calls this week: Tesla, Microsoft and Illumina among top picks
The S&P500 (SP500) closed in the red on Friday, after the week saw major headlines including President Trump announcing to put a 50% tariff on copper imports after saying no to August 1 deadline exten...
07-12 21:35
